Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Regen BioPharma Inc issued 11,111,111 common shares of common stock for $50,000.
- Security
- common stock
- Shares
- 11,111,111 common shares
- Consideration
- $50,000
Exact text from the filing
On January 30, 2026 the Company issued 11,111,111 common shares (“Shares”) for consideration consisting of $50,000.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Regen BioPharma Inc issued 5,302,732 common shares of common stock for $12,000 of principal convertible indebtedness and $1,000 of accrued interest.
- Security
- common stock
- Shares
- 5,302,732 common shares
- Consideration
- $12,000 of principal convertible indebtedness and $1,000 of accrued interest
Exact text from the filing
On January 29, 2026 the Company issued 5,302,732 common shares (“Shares”) in satisfaction of $12,000 of principal convertible indebtedness and $1,000 of accrued interest on convertible indebtedness.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Regen BioPharma Inc issued 5,000,000 common shares of common stock for $11,449 of principal convertible indebtedness and $8,101 of accrued interest.
- Security
- common stock
- Shares
- 5,000,000 common shares
- Consideration
- $11,449 of principal convertible indebtedness and $8,101 of accrued interest
Exact text from the filing
On January 15, 2026 the Company issued 5,000,000 common shares (“Shares”) in satisfaction of $11,449 of principal convertible indebtedness and $8,101 of accrued interest on convertible indebtedness.
View on SEC.gov